Alkami director granted 674 deferred shares
Alvarez Maria Ines reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Alvarez Maria Ines reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director Maria Ines Alvarez received an award of 674 shares of Common Stock on April 5, 2026 at a stated price of $0.00 per share. This was a grant under the company’s 2021 Incentive Award Plan, and she elected to defer receipt of these shares under that plan. Following this award, she directly holds 58,552 shares of Common Stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 674 | $0.00 | $0.00 |
Footnotes (1)
- F1. The reporting person elected to defer receipt of these shares under the terms of the 2021 Incentive Award Plan.
Key Figures
Key Terms
2021 Incentive Award Plan financial
defer receipt financial
Common Stock financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ALKT director Maria Ines Alvarez report on this Form 4?
Was the ALKT stock grant to director Maria Ines Alvarez an open-market purchase or compensation award?
Does the ALKT Form 4 show any stock sales or dispositions by Maria Ines Alvarez?
AI-generated analysis. How Rhea-AI works. Not financial advice.